JSM 2005 - Toronto

JSM Activity #323

This is the preliminary program for the 2005 Joint Statistical Meetings in Minneapolis, Minnesota. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2005); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.



The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

The Program has labeled the meeting rooms with "letters" preceding the name of the room, designating in which facility the room is located:

Minneapolis Convention Center = “MCC” Hilton Minneapolis Hotel = “H” Hyatt Regency Minneapolis = “HY”

Back to main JSM 2005 Program page
Legend: = Applied Session, = Theme Session, = Presenter
Add To My Program
323 Tue, 8/9/05, 2:00 PM - 3:50 PM MCC-200 H
Missing Data Issues - Contributed - Papers
Biopharmaceutical Section, WNAR
Chair(s): Ivan S.F. Chan, Merck Research Laboratories
     2:05 PM   A Comparison of Imputation Methods for Missing Data on Clinical Laboratory Assessments — Kapildeb Sen, Bristol-Myers Squibb Company; Chen-Sheng Lin, Bristol-Myers Squibb Company; Kannan Natarajan, Bristol-Myers Squibb Company
     2:20 PM   Including Adverse Event Data in Multiple Imputation of Efficacy Outcomes — Craig Mallinckrodt, Eli Lilly and Company; Shuyi Shen, Eli Lilly and Company; Xue Xin, Eli Lilly and Company; Hua Deng, Eli Lilly and Company; Ilya Lipkovich, Eli Lilly and Company; Geert Molenberghs, Limburgs Universitair Centrum
     2:35 PM   Does Imputation Help Your Power? — John Johnson, Rho, Inc.
     2:50 PM   Missing Data in Longitudinal Controlled Clinical Trial: A Power Comparison for Intent-to-treat Analysis — Hrishikesh Chakraborty, RTI International; Hong Gu, Dalhousie University
     3:05 PM   A Bias Correction in Testing Treatment Efficacy under Informative Drop-out in Clinical Trials — Fanhui Kong, U.S. Food and Drug Administration; Yeh-Fong Chen, U.S. Food and Drug Administration; Kun Jin, U.S. Food and Drug Administration
     3:20 PM   Missing Data in Safety Evaluation: Analyses and Issues — Satish Misra, U.S. Food and Drug Administration
     3:35 PM   Floor Discussion
 

JSM 2005 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2005